1987
DOI: 10.1016/0165-0378(87)90051-9
|View full text |Cite
|
Sign up to set email alerts
|

Establishment and characterization of a human hybridoma secreting monoclonal antibody with high titers of sperm immobilizing and agglutinating activities against human seminal plasma

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
45
0

Year Published

1988
1988
2023
2023

Publication Types

Select...
5
5

Relationship

1
9

Authors

Journals

citations
Cited by 90 publications
(47 citation statements)
references
References 6 publications
1
45
0
Order By: Relevance
“…CD52 has been identified as a potential target for antisperm carbohydrate antibodies involved in immune infertility [75]. In a benchmark study, Isojima et al [86] established a human-mouse heterohybridoma using peripheral blood lymphocytes from an infertile woman who exhibited high sperm-inhibitory titers. …”
Section: Immune Infertilitymentioning
confidence: 99%
“…CD52 has been identified as a potential target for antisperm carbohydrate antibodies involved in immune infertility [75]. In a benchmark study, Isojima et al [86] established a human-mouse heterohybridoma using peripheral blood lymphocytes from an infertile woman who exhibited high sperm-inhibitory titers. …”
Section: Immune Infertilitymentioning
confidence: 99%
“…The absorbance was determined at 495 nm using an RM ELISA reader (Dynatech AG, Branch Germany, Denkendorf, Germany). For sperm ELISA (Isojima et al, 1987), the microELISA plates were filled with 50 pi of a suspension of washed boar, rabbit or bull ejaculated spermatozoa (6 IO6 cells ml-1), air dried at room temperature and incubated overnight at 4°C. Protein binding sites of the wells were blocked by blocking buffer (PBS, 1 % BSA, 2% normal porcine serum) for 1 h at 22°C.…”
Section: Capacitationmentioning
confidence: 99%
“…Human IgG has a half‐life of 21 days. Recently, there has been a growing interest to humanize the murine monoclonal antibodies or to raise human monoclonal antibodies against various sperm contraceptive epitopes (Isojima et al, 1987; Clayton et al, 1998; Norton et al, 2001). These antibodies, and additional antibodies that are being engineered, await trials in animal models and in humans for demonstration of efficacy, duration, and reversibility of the antifertility effects.…”
Section: Sperm Antigensmentioning
confidence: 99%